merk-m-logo-blue

INFOSHEET

FROM PATIENT TO PLATFORM

Learn how we develop patient-derived organoids for modelling diseases and how can they be applied in drug discovery & development

Download the infosheet to discover:

  • How patient-derived organoids are developed step-by-step
  • The history and innovation behind HUB’s pioneering organoid technology
  • How organoid screening accelerates drug development with scalable, reproducible assays
  • What our living biobank offers for contract research and collaboration

Download our info sheet

Trust in the pioneers of Organoid Technology

2009

First organoid generated from mouse intestine

2011

First human organoid developed from intestinal epithelium

2013

Hubrecht Organoid Technology Foundation was established to upscale and commercialize organoid technology

2015

First cystic fibrosis patient treated based on organoid data

2017

HIT-CF validation trial launched

2018

First oncology clinical candidate entirely developed using organoid screening approved for clinical trials

2022

Expansion of lab facilities

2023

Hubrecht Organoid Technology becomes HUB Organoids B.V.